Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Hematology Reports|April 19, 2019
Relapsing thrombotic thrombocytopenic purpura with low ADAMTS13 antigen levels: An indication for splenectomy?Anna Maria Lombardi, Irene Di Pasquale, Maria Antonietta Businaro, et al.
Thrombosis and Haemostasis|May 1, 2010
Nitric oxide derivatives and soluble plasma selectins in patients with myeloproliferative neoplasmsGiuseppe Cella, Marina Marchetti, Fabrizio Vianello, et al.
Hematology Reports|April 9, 2014
Serum Thrombopoietin and cMpl Expression in Thrombocytopenia of Different EtiologiesFabrizio Vianello, Silvia Vettore, Fabiana Tezza, et al.
Current Opinion in Allergy and Clinical Immunology|October 29, 2025
When immunity turns rogue: lymphoma and lymphoproliferative disorders in common variable immune deficiencyBianca Sciacca, Marianna Franco, Giulia Gualtiero, et al.
Haematologica|October 14, 2011
A A386G biallelic GPIbα gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesisSilvia Vettore, Fabiana Tezza, Alessandro Malara, et al.
Cells|February 25, 2025
Shaping Rare Granulomatous Diseases in the Lab: How New Models Are Changing the GameJessica Ceccato, Giulia Gualtiero, Maria Piazza, et al.
Infection|April 15, 2026
Bartonella henselae infection associated with a multisystemic thrombo-inflammatory syndrome in an immunocompetent adultGiovanni Gobbo, Marco Zacchia, Federico Nalesso, et al.
American Journal of Hematology|October 30, 2014
Coronary microvascular dysfunction due to essential thrombocythemia and policythemia vera: the missing piece in the puzzle of their increased cardiovascular risk?Fabrizio Vianello, Giuseppe Cella, Elena Osto, et al.
Ejhaem|March 13, 2026
Scleredema Associated With IgG/κ Monoclonal Gammopathy of Clinical Significance Successfully Treated With Daratumumab Monotherapy: A Case ReportDavide Marcolongo, Alessandra Bressan, Elisabetta Zanatta, et al.
Haematologica|February 25, 2010
Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axisFabrizio Vianello, Federica Villanova, Veronica Tisato, et al.
Pageof 7